These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 18754907
21. Botulinum toxin type a injections to salivary glands: combination with single event multilevel chemoneurolysis in 2 children with severe spastic quadriplegic cerebral palsy. Kim H, Lee Y, Weiner D, Kaye R, Cahill AM, Yudkoff M. Arch Phys Med Rehabil; 2006 Jan; 87(1):141-4. PubMed ID: 16401453 [Abstract] [Full Text] [Related]
22. 'Why do children with cerebral palsy discontinue therapy with botulinum toxin A?'. Linder-Lucht M, Kirschner J, Herrmann J, Geth K, Korinthenberg R, Berweck S, Heinen F, Mall V. Dev Med Child Neurol; 2006 Apr; 48(4):319-20. PubMed ID: 16542523 [No Abstract] [Full Text] [Related]
24. Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance. Py AG, Zein Addeen G, Perrier Y, Carlier RY, Picard A. Ann Phys Rehabil Med; 2009 Apr; 52(3):215-23. PubMed ID: 19447084 [Abstract] [Full Text] [Related]
25. How do we treat pediatric patients with spastic diplegia? Dai AI. Pediatr Phys Ther; 2006 Apr; 18(4):306; author reply 306-7. PubMed ID: 17108805 [No Abstract] [Full Text] [Related]
28. Secondary non-response due to development of neutralising antibodies to botulinum toxin A during treatment of children with cerebral palsy. Herrmann J, Mall V, Bigalke H, Geth K, Korinthenberg R, Heinen F. Neuropediatrics; 2000 Dec; 31(6):333-4. PubMed ID: 11508557 [No Abstract] [Full Text] [Related]
29. Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children. Kumar R, Sneade C, Littler K. Dev Med Child Neurol; 2009 Oct; 51(10):838-9. PubMed ID: 19747281 [No Abstract] [Full Text] [Related]
32. Long-term use of botulinum toxin type A in children with cerebral palsy: treatment consistency. Molenaers G, Schörkhuber V, Fagard K, Van Campenhout A, De Cat J, Pauwels P, Ortibus E, De Cock P, Desloovere K. Eur J Paediatr Neurol; 2009 Sep; 13(5):421-9. PubMed ID: 18977158 [Abstract] [Full Text] [Related]
34. Long-term effects of botulinum toxin A in children with cerebral palsy. Tedroff K, Granath F, Forssberg H, Haglund-Akerlind Y. Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845 [Abstract] [Full Text] [Related]
35. [Management of spastic cerebral palsy with botulinum-A toxin: relationship between dosage and efficacy]. Wang YJ, Yan GY, Gao BQ. Zhongguo Dang Dai Er Ke Za Zhi; 2007 Jun; 9(3):247-8. PubMed ID: 17582266 [No Abstract] [Full Text] [Related]
36. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy. Hawamdeh ZM, Ibrahim AI, Al-Qudah AA. Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388 [Abstract] [Full Text] [Related]
38. The short-term effects of combined modified constraint-induced movement therapy and botulinum toxin injection for children with spastic hemiplegic cerebral palsy. Park ES, Rha DW, Lee JD, Yoo JK, Chang WH. Neuropediatrics; 2009 Dec; 40(6):269-74. PubMed ID: 20446220 [Abstract] [Full Text] [Related]
40. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus. Newman CJ, Kennedy A, Walsh M, O'Brien T, Lynch B, Hensey O. J Pediatr Orthop; 2007 Dec; 27(8):882-5. PubMed ID: 18209608 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]